Amgen Inc (NASDAQ:AMGN)
| 224.72 Delayed Data As of Feb 26 |  -2.80 / -1.23%Today’s Change | 177.05 Today|||52-Week Range 276.69 | -2.26% Year-to-Date |
Latest AMGN News | Press Releases
| Radius' (RDUS) Q4 Loss Wider Than Expected, Revenues Beat Feb 26 / Zacks.com - Paid Partner Content | 2 Best Pharma Stocks to Buy Right Now Feb 23 / MotleyFool.com - Paid Partner Content |
| Merck Makes Another Move to Beef Up Drug Business Feb 25 / GuruFocus News - Paid Partner Content | Biotech Stock Roundup: REGN's Drug Approval & Pipeline Updates From AMGN, BLUE Feb 17 / Zacks.com - Paid Partner Content |
| Why Turning Point Is Turning Heads Feb 23 / MotleyFool.com - Paid Partner Content | The Zacks Analyst Blog Highlights: Toyota, PepsiCo, BlackRock, Amgen and Allstate Feb 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 227.52 |
| Today’s open | 230.00 |
| Day’s range | 223.00 - 230.64 |
| Volume | 218,793 |
| Average volume (3 months) | 2,513,409 |
| Market cap | $129.9B |
Data as of 4:09pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -4.37% |
| Earnings growth (this year) | +1.38% |
| Earnings growth (next 5 years) | +6.15% |
| Revenue growth (last year) | +8.53% |
| P/E ratio | 18.3 |
| Price/Sales | 5.37 |
| Price/Book | 13.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -1.39 | -2.21% |
| ILMNIllumina Inc | -6.44 | -1.44% |
| MRNAModerna Inc | +6.55 | +4.41% |
| BIIBBiogen | -4.90 | -1.77% |
Data as of 4:18pm ET, 02/26/2021
Financials
| Next reporting date | April 28, 2021 |
| EPS forecast (this quarter) | $4.08 |
| Annual revenue (last year) | $25.2B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 28.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
